Details for New Drug Application (NDA): 208691
✉ Email this page to a colleague
NDA 208691 describes SIROLIMUS, which is a drug marketed by Amneal, Apotex, Hetero Labs Ltd V, MSN, Novitium Pharma, Rising, Torrent, Alkem Labs Ltd, Dr Reddys, Glenmark Pharms Ltd, and Zydus Pharms, and is included in eleven NDAs. It is available from sixteen suppliers. Additional details are available on the SIROLIMUS profile page.
The generic ingredient in SIROLIMUS is sirolimus. There are twenty-one drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the sirolimus profile page.
The generic ingredient in SIROLIMUS is sirolimus. There are twenty-one drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the sirolimus profile page.
Summary for 208691
| Tradename: | SIROLIMUS |
| Applicant: | Glenmark Pharms Ltd |
| Ingredient: | sirolimus |
| Patents: | 0 |
Pharmacology for NDA: 208691
| Mechanism of Action | Protein Kinase Inhibitors mTOR Inhibitors |
| Physiological Effect | Decreased Immunologic Activity |
Medical Subject Heading (MeSH) Categories for 208691
Suppliers and Packaging for NDA: 208691
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| SIROLIMUS | sirolimus | TABLET;ORAL | 208691 | ANDA | NORTHSTAR RX LLC | 16714-187 | 16714-187-01 | 100 TABLET, FILM COATED in 1 BOTTLE (16714-187-01) |
| SIROLIMUS | sirolimus | TABLET;ORAL | 208691 | ANDA | NORTHSTAR RX LLC | 16714-188 | 16714-188-01 | 100 TABLET, FILM COATED in 1 BOTTLE (16714-188-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 0.5MG | ||||
| Approval Date: | Oct 16, 2020 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 1MG | ||||
| Approval Date: | Oct 16, 2020 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 2MG | ||||
| Approval Date: | Oct 16, 2020 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
